Daiichi Sankyo Leads Japan Pharma Stocks Higher on Cancer Drug

📆 25/9/2023 2:38 PM
📰 YahooFinanceCA

⏱ Reading Time:
14 sec. here
2 min. at publisher
📊 Quality Score:
News: 9%
Publisher: 63%

Malaysia News News

Malaysia Malaysia Latest News,Malaysia Malaysia Headlines

(Bloomberg) -- Daiichi Sankyo Co. shares jumped by the most in a year after a drug it developed with AstraZeneca Plc showed favorable results in a trial for a common type of breast cancer.Most Read from BloombergChinese Gold Buying Is Driving a Paradigm Shift in BullionStocks Flash Recession Warning as Trouble Spreads to IndustrialsIndia-Canada Clash Should Be a Wakeup CallWells Fargo Preps for Wealth Battle After $1 Billion TurnaroundCorzine Plans to Shut Hedge Fund and Return Capital to Invest

Awkward Encounters: Pushing Limits of EmbarrassmentSome providers are dropping gender-affirming care for kids even in cases where it's legal

ST. LOUIS — As Republican-led states have rushed to ban gender-affirming for minors, some families with transgender children found a bit of solace: At least they lived in states that would allow those already receiving puberty blockers or hormone therapy to continue.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Write Comment

Malaysia Malaysia Latest News, Malaysia Malaysia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Daiichi Sankyo Leads Japan Pharma Stocks Higher on Cancer DrugDaiichi Sankyo Co. shares jumped by the most in a year after a drug it developed with AstraZeneca Plc showed favorable results in a trial for a common type of breast cancer.
Source: BNNBloomberg - 🏆 83. / 50 Read more »